Cargando…
Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5‐WT1‐E‐cadherin signalling pathway in pancreatic ductal adenocarcinoma
Wilm's tumour‐1 (WT1) is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and enhances metastasis. Deubiquitination stabilizes target proteins, and inhibiting deubiquitination facilitates the degradation of target proteins. However, whether inhibiting deubiquitination of WT1 facilitates...
Autores principales: | Li, Jiajia, Li, Haiying, Zhu, Weijian, Zhou, Bin, Ying, Jianchao, Wu, Jiansheng, Zhang, Huxiang, Sun, Hongwei, Gao, Shenmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991651/ https://www.ncbi.nlm.nih.gov/pubmed/31845546 http://dx.doi.org/10.1111/jcmm.14813 |
Ejemplares similares
-
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
por: Pérez-Mancera, Pedro A., et al.
Publicado: (2012) -
Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
por: Chen, Junjie, et al.
Publicado: (2016) -
Erratum to: Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers
por: Chen, Junjie, et al.
Publicado: (2017) -
Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2
por: Li, Wenyang, et al.
Publicado: (2020) -
Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)